The reduction in incidence of hypoglycemia, in particular nocturnal hypoglycemia, seen here, and in other studies with IDet, suggests that more aggressive titration of insulin dose may be possible to achieve better glycemic control and reduce the development of future macro-and microvascular complications. The gene discussed is INS; the disease is Hypoglycemia.